TODAY’S PATENT – METHOD TO TREAT GASTRIC REFLUX VIA THE DETECTION AND ABLATION OF GASTRO-ESOPHAGEAL NERVES AND RECEPTORS
Today’s invention was invented by Stuart D. Edwards, John Gaiser and David S. Utley which is currently assigned to Mederi Therapeutics Inc. The invention was patented by USPTO on 18th June, 2002 bearing patent No. US6405732B1.
The invention is used to treat gastroesophageal reflux, and more particularly the detection and ablation and/or necrosis of gastroesophageal nerves and receptors causing transient relaxation of the lower esophageal sphincter and gastroesophageal reflux.
The sphincter electropotential mapping device with at least one of a mapping electrode or a treatment electrode is introduced into at least a portion of the sphincter, the lower esophageal sphincter, stomach, the cardia or the fundus. It is stimulated to produce a transient relaxation of the sphincter. On detection of relaxation, energy is delivered from the sphincter electropotential mapping device to treat the portion the sphincter, lower esophageal sphincter, stomach, cardia or fundus causing the transient relaxation of the sphincter.